Maeve O’meara Sells 38,140 Shares of Castlight Health Inc (NYSE:CSLT) Stock

Castlight Health Inc (NYSE:CSLT) CEO Maeve O’meara sold 38,140 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $1.23, for a total transaction of $46,912.20. Following the transaction, the chief executive officer now directly owns 357,301 shares in the company, valued at $439,480.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Maeve O’meara also recently made the following trade(s):

  • On Thursday, January 2nd, Maeve O’meara sold 17,070 shares of Castlight Health stock. The stock was sold at an average price of $1.29, for a total transaction of $22,020.30.

Shares of NYSE:CSLT traded up $0.03 during midday trading on Wednesday, hitting $1.28. The company’s stock had a trading volume of 108,807 shares, compared to its average volume of 562,249. The stock has a market capitalization of $186.37 million, a price-to-earnings ratio of -5.82 and a beta of 1.42. The stock’s 50 day simple moving average is $1.30 and its 200 day simple moving average is $1.40. Castlight Health Inc has a fifty-two week low of $1.01 and a fifty-two week high of $4.15. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.84 and a current ratio of 1.84.

CSLT has been the topic of several analyst reports. Wells Fargo & Co downgraded shares of Castlight Health from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $1.75 to $1.20 in a research report on Wednesday, January 8th. ValuEngine raised shares of Castlight Health from a “hold” rating to a “buy” rating in a research report on Friday, January 3rd. Canaccord Genuity lowered their target price on shares of Castlight Health from $4.00 to $1.50 in a research report on Wednesday, November 27th. Finally, Zacks Investment Research raised shares of Castlight Health from a “sell” rating to a “hold” rating in a research report on Monday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $2.07.

Several large investors have recently modified their holdings of CSLT. Raging Capital Management LLC acquired a new stake in shares of Castlight Health in the third quarter valued at about $7,320,000. Renaissance Technologies LLC grew its position in shares of Castlight Health by 25.7% in the fourth quarter. Renaissance Technologies LLC now owns 2,299,550 shares of the software maker’s stock valued at $3,058,000 after purchasing an additional 469,950 shares during the last quarter. Jacobs Levy Equity Management Inc. grew its position in shares of Castlight Health by 37.6% in the fourth quarter. Jacobs Levy Equity Management Inc. now owns 803,245 shares of the software maker’s stock valued at $1,068,000 after purchasing an additional 219,544 shares during the last quarter. Squarepoint Ops LLC grew its position in shares of Castlight Health by 100.0% in the third quarter. Squarepoint Ops LLC now owns 323,424 shares of the software maker’s stock valued at $456,000 after purchasing an additional 161,715 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in shares of Castlight Health by 88.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 267,655 shares of the software maker’s stock valued at $356,000 after purchasing an additional 125,398 shares during the last quarter. 53.10% of the stock is currently owned by institutional investors.

About Castlight Health

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.

Further Reading: FinTech

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.